5782-69-4

Basic information

• Product Name: 3-Pyridinecarbonitrile,1,2-dihydro-6-(1-methylethyl)-2-oxo-(9CI)
• Synonyms: 3-Pyridinecarbonitrile,1,2-dihydro-6-(1-methylethyl)-2-oxo-(9CI);3-Cyano-6-isopropyl-2-hydroxypyridine;6-Isopropyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile;3-Pyridinecarbonitrile, 1,2-dihydro-6-(1-Methylethyl)-2-oxo-;1,2-dihydro-6-(1-methylethyl)-2-oxo-3-Pyridinecarbonitrile
• CAS NO: 5782-69-4
• Molecular Formula: C9H10N2O
• Molecular Weight: 162.191
• Product Categories: ISOPROPYL
• Mol File: 5782-69-4.mol
• Article Data: 8

Chemical Properties

• Melting Point: 203-204 °C(Solv: water (7732-18-5))
• Boiling Point: 342.5±35.0 °C(Predicted)
• Appearance: /
• Density: 1.12±0.1 g/cm3(Predicted)
• PKA: 8.83±0.10(Predicted)
• CAS DataBase Reference: 3-Pyridinecarbonitrile,1,2-dihydro-6-(1-methylethyl)-2-oxo-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarbonitrile,1,2-dihydro-6-(1-methylethyl)-2-oxo-(9CI)(5782-69-4)
• EPA Substance Registry System: 3-Pyridinecarbonitrile,1,2-dihydro-6-(1-methylethyl)-2-oxo-(9CI)(5782-69-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 5782-69-4(Hazardous Substances Data)

Usage

General Description

3-Pyridinecarbonitrile, 1,2-dihydro-6-(1-methylethyl)-2-oxo (9CI) is a chemical compound with the molecular formula C11H13N3O. It is a derivative of pyridine and is also known by the name "cipralan." 3-Pyridinecarbonitrile,1,2-dihydro-6-(1-methylethyl)-2-oxo-(9CI) is a yellow liquid with a melting point of approximately 42-44°C. It is used in the manufacturing of pharmaceuticals, agrochemicals, and other organic compounds. Additionally, it has potential applications in the field of medicinal chemistry for the development of new drugs and therapeutic agents. Overall, 3-Pyridinecarbonitrile, 1,2-dihydro-6-(1-methylethyl)-2-oxo (9CI) is a versatile chemical with various industrial and research applications.

Upstream product

• 31086-95-0 1,1-diethoxy-4-methyl-pentan-3-one 
• 107-91-5 cyanoacetic acid amide 
• 55793-14-1 4-methyl-3-oxo-pentanal; sodium enolate 
• 4241-27-4 1,2-dihydro-6-methyl-2-oxo-3-pyridinecarbonitrile 
• 74-88-4 methyl iodide 
• 563-80-4 3-methyl-butan-2-one 
• 5782-56-9 1-(dimethylamino)-4-methylpent-1-en-3-one 
• 109-94-4 formic acid ethyl ester 
• 121017-76-3 ethyl 5-cyano-1,6-dihydro-2-isopropyl-6-oxo-3-pyridine carboxylate 
• 116344-09-3 2-dimethylaminomethylene-4-methyl-3-oxo-pentanoic acid ethyl ester 
• 88785-54-0 (Z)-1-Amino-4-methyl-pent-1-en-3-one 
• 4370-12-1 1-cyanoformamide 
• 109-77-3 malononitrile 
• 121017-82-1 5-Cyano-2-isopropyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid 

Downstream Products

• 62969-85-1 6-isopropyl-pyridin-2-ol 
• 1365921-39-6 C₂₃H₂₂N₄S 
• 944503-88-2 C₂₅H₂₅N₅OS 
• 944503-77-9 C₂₃H₂₂N₄OS 
• 944503-94-0 C₂₄H₂₄N₄OS 
• 1365921-60-3 C₂₃H₂₁FN₄S 
• 943771-01-5 2-amino-6-isopropyl-nicotinonitrile 
• 1416146-34-3 (R)-5-bromo-6-isopropyl-2-(4-(4-methoxybenzyl)-3-methylpiperazin-1-yl)nicotinonitrile 
• 1416146-08-1 (R)-5-(4-fluorophenyl)-6-isopropyl-2-(4-(4-methoxybenzyl)-3-methylpiperazin-1-yl)nicotinonitrile 
• 1416146-09-2 (R)-5-(4-fluorophenyl)-6-isopropyl-2-(4-(4-methoxybenzyl)-3-methylpiperazin-1-yl)nicotinic acid 
• 1416146-35-4 (R)-methyl 5-(4-fluorophenyl)-6-isopropyl-2-(3-methylpiperazin-1-yl)nicotinate 
• 943776-92-9 morpholine-4-carboxylic acid {4-[4-(4-bromo-phenylcarbamoyl)-2-(7-isopropyl-pyrido[2,3-d]pyrimidin-4-ylamino)-phenoxy]-phenyl}-amide trifluoroacetate 
• 1076222-56-4 furan-2-carboxylic acid [4-(4-hydroxy-phenylsulfanyl)-3-(7-isopropyl-pyrido[2,3-d]pyrimidin-4-ylamino)-phenyl]amide trifluoroacetate 
• 943776-95-2 {4-[4-(4-bromo-phenylcarbamoyl)-2-(7-isopropyl-pyrido[2,3-d]pyrimidin-4-ylamino)-phenoxy]-phenyl}-carbamic acid 2,2,2-trichloro-ethyl ester 

Relevant articles and documents

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

Provided are compounds with the following structure, formula (I) pharmaceutically acceptable salts thereof, use of those compounds for treating cancer and pharmaceutical compositions comprising those compounds.

ANTI-VIRAL COMPOUNDS

Compounds effective in inhibiting replication of Hepatitis C virus ( HCV ) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, coformulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Synthesis and solid-state structures of alkyl-substituted 3-cyano-2-pyridones

A series of 3-cyano-pyridones carrying a variety of alkyl substituents at C-5 and C-6 has been synthesized and their solid-state structures have been studied. Hydrogen bonding interactions between individual pyridone molecules lead either to the formation of symmetric dimers of the R2 2(8) type or to helical chains of the C(4) type. Based on known and calculated structures for the 2-pyridone parent system, the solid-state structures can be divided in two groups representing cases with little external influence on the hydrogen bonding array (group A) and those with a larger external influence (group B).